1727.5000 44.90 (2.67%)
NSE Jul 15, 2025 15:31 PM
Volume: 3.3M
 

Reliance Securities
SUNP has reported a strong performance in 1QFY19 on the back of healthy growth across geographies. On positive note, it completed the transition in distribution in India business from AML to WOS, following which it reported 12% YoY underlining growth and expects better-thancovered-market growth of 9-10%. Though SUNP had addressed some corporate governance issues raised by the investors, we see the SEBI-related issues continue to remain event-specific risk for the stock in the near-term. Owing to increasing visibility in India and other businesses,...
Sun Pharmaceutical Industries Ltd. is trading above its 100 day SMA of 1700.0
More from Sun Pharmaceutical Industries Ltd.
Recommended